摘要
目的:探讨COX2对卵巢癌细胞株增殖及迁移的影响及其相关机制。方法:构建慢病毒载体Lenti-COX2-EGFP,转染卵巢癌细胞株SKOV3和ES2。PCR及Western blot法鉴定转染效率,CCK-8实验检测细胞增殖,划痕实验观察细胞迁移能力,qRTPCR法检测E-cadherin、Vimentin、Snail和Slug表达。结果:与对照组相比,过表达COX2后卵巢癌细胞的增殖和迁移能力增强,差异均有统计学意义(P<0.05);E-cadherin表达下调,Snail、Slug、Vimentin表达上调。COX2抑制剂塞来昔布处理则可抑制COX2过表达细胞的增殖及迁移能力,与对照组比较差异有统计学意义(P<0.05)。结论:COX2可促进卵巢癌细胞增殖及上皮间质转化(EMT)继而增强肿瘤细胞迁移能力;塞来昔布可发挥阻断作用。推测COX2可能是卵巢癌临床治疗的一个潜在靶点。
Objective: To examine whether COX2 could accelerate proliferation and metastases of ovarian cancer cells and its related mechanisms. Methods: We created LentiCOX2-EGFP and then transfected ovarian cancer cells. After that,we evaluated the effect of COX2 on proliferation and metastases of ovarian cancer via PCR,Western blot,qRT-PCR,CCK-8 test and healing test. Results: Compare with control group,after up-regulating COX2 expression,cell proliferation and migration accelerated. The expressions of Snail and Slug up-regulated,resulting in E-cadherin expression down-regulating and Vimentin expression up-regulating.Celecoxib can inhibit these affections. All of the differences were significant. Conclusion: COX2 can accelerate cell proliferation and EMT,which can accelerate migration. Celecoxib can inhibit this effect. So,COX2 may serve as a potential target for curing ovarian cancer.
出处
《现代妇产科进展》
CSCD
北大核心
2016年第8期561-565,共5页
Progress in Obstetrics and Gynecology
基金
国家自然科学基金资助项目(No:81372777
81372779)
关键词
卵巢癌
COX2
增殖
转移
EMT
Ovarian cancer
COX2
Proliferation
Metastasis
EMT